{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:35:41Z","timestamp":1789896941944,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1016\/j.radonc.2006.07.030","type":"journal-article","created":{"date-parts":[[2006,8,18]],"date-time":"2006-08-18T11:13:23Z","timestamp":1155899603000},"page":"214-222","source":"Crossref","is-referenced-by-count":30,"title":["TRAIL enhances efficacy of radiotherapy in a p53 mutant, Bcl-2 overexpressing lymphoid malignancy"],"prefix":"10.1016","volume":"80","author":[{"given":"Esther H.J.","family":"Wissink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Verbrugge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R.","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela B.","family":"Schader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Walczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannie","family":"Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2006.07.030_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and anti-tumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.radonc.2006.07.030_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1044-5323(03)00031-9","article-title":"The CD95 Type I\/Type II model","volume":"15","author":"Barnhart","year":"2003","journal-title":"Sem Immunol"},{"key":"10.1016\/j.radonc.2006.07.030_bib3","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0959-8049(01)00363-X","article-title":"The combined use of radiotherapy and chemotherapy in the treatment of solid tumors","volume":"38","author":"Bartelink","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2006.07.030_bib4","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.onc.1204318","article-title":"Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL","volume":"20","author":"Belka","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2006.07.030_bib5","doi-asserted-by":"crossref","first-page":"14255","DOI":"10.1074\/jbc.274.20.14255","article-title":"Common regulation of apoptosis signaling induced by CD95 and the DNA damaging stimuli etoposide and \u03b3 radiation downstream from Caspase-8","volume":"274","author":"Boesen-de Cock","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.radonc.2006.07.030_bib6","first-page":"1391","article-title":"Apoptosis, p53, and tumor cell sensitivity to anticancer agents","volume":"59","author":"Brown","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2006.07.030_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1535-6108(02)00122-8","article-title":"Stable suppression of tumorigenicity by virus-mediated RNA interference","volume":"2","author":"Brummelkamp","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.radonc.2006.07.030_bib8","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1073\/pnas.030545097","article-title":"Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy","volume":"97","author":"Chinnaiyan","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.radonc.2006.07.030_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","article-title":"Cell death: critical control points","volume":"116","author":"Danial","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.radonc.2006.07.030_bib10","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood.V97.9.2596","article-title":"Ionizing radiation sensitizes erythroleukemic cells but not normal erythroblasts to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by selective upregulation of TRAIL-R1","volume":"97","author":"DiPietro","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2006.07.030_bib11","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1158\/1078-0432.CCR-05-2635","article-title":"Preclinical differentiation between apparently safe and potentially hepatotoxic applications of TRAIL either alone or in combination with chemotherapeutic drugs","volume":"12","author":"Ganten","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2006.07.030_bib12","first-page":"5754","article-title":"Apo2 ligand\/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells","volume":"60","author":"Gong","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2006.07.030_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jcp.1101","article-title":"Evidence that the death receptor DR4 is a DNA damage-inducible, p53 regulated gene","volume":"188","author":"Guan","year":"2001","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.radonc.2006.07.030_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1535-6108(03)00244-7","article-title":"Puma is an essential mediator of p53-dependent and -independent apoptotic pathways","volume":"4","author":"Jeffers","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.radonc.2006.07.030_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0092-8674(02)00625-6","article-title":"Apoptosis: a link between cancer genetics and chemotherapy","volume":"108","author":"Johnstone","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.radonc.2006.07.030_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3565(24)29298-3","article-title":"Preclinical studies to predict the disposition of Apo2L\/Tumor Necrosis Factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety","volume":"299","author":"Kelley","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.radonc.2006.07.030_bib17","doi-asserted-by":"crossref","first-page":"40044","DOI":"10.1074\/jbc.M404541200","article-title":"Death induction by recombinant native TRAIL and its prevention by a Caspase 9 inhibitor in primary human esophageal epithelial cells","volume":"279","author":"Kim","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.radonc.2006.07.030_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2407-5-5","article-title":"Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis","volume":"5","author":"Marini","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2006.07.030_bib19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","article-title":"PUMA, a novel proapoptotic gene, is induced by p53","volume":"7","author":"Nakano","year":"2001","journal-title":"Mol Cell"},{"key":"10.1016\/j.radonc.2006.07.030_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.radonc.2006.07.030_bib21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","article-title":"Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis","volume":"288","author":"Oda","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.radonc.2006.07.030_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.cdd.4401186","article-title":"The CD95(APO-1\/Fas) DISC and beyond","volume":"10","author":"Peter","year":"2003","journal-title":"Cell Death Diff"},{"key":"10.1016\/j.radonc.2006.07.030_bib23","first-page":"1583","article-title":"Requirement of BAX for TRAIL\/Apo2L-induced apoptosis of colorectal cancers: synergism with Sulindac-mediated inhibition of Bcl-xL","volume":"62","author":"Ravi","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2006.07.030_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.4161\/cbt.2.6.626","article-title":"Caspase-10 levels are increased following DNA damage in a p53-dependent manner","volume":"2","author":"Rikhof","year":"2003","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.radonc.2006.07.030_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/pros.20069","article-title":"Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: intracellular mechanisms","volume":"15","author":"Shankar","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.radonc.2006.07.030_bib26","first-page":"1133","article-title":"The sequential treatment with ionizing radiation followed by TRAIL\/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice","volume":"24","author":"Shankar","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.radonc.2006.07.030_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0092-8674(94)90201-1","article-title":"DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2","volume":"79","author":"Strasser","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.radonc.2006.07.030_bib28","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1158\/0008-5472.CAN-03-1339","article-title":"Human telomerase reverse transcriptase-transduced human cytotoxic T cells suppress the growth of human melanoma in immunodeficient mice","volume":"15","author":"Verra","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2006.07.030_bib29","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1090072","article-title":"p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa","volume":"302","author":"Villunger","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.radonc.2006.07.030_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5517","article-title":"Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo","volume":"5","author":"Walczak","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2006.07.030_bib31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/sj.cdd.4401263","article-title":"A new quantitative assay for cytochrome c release in apoptotic cells","volume":"10","author":"Waterhouse","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.radonc.2006.07.030_bib32","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1182\/blood.V99.8.2752","article-title":"Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo","volume":"99","author":"Weijer","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2006.07.030_bib33","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1038\/sj.onc.1208580","article-title":"TRAIL sensitizes for ionizing irradiation-induced apoptosis through an entirely Bax-dependent mitochondrial cell death pathway","volume":"24","author":"Wendt","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2006.07.030_bib34","doi-asserted-by":"crossref","first-page":"22781","DOI":"10.1074\/jbc.M201469200","article-title":"Bcl-2 family member Bfl-1\/A1 sequesters truncated Bid to inhibit its collaboration with pro-apoptotic Bak or Bax","volume":"277","author":"Werner","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.radonc.2006.07.030_bib35","doi-asserted-by":"crossref","first-page":"28771","DOI":"10.1074\/jbc.M400268200","article-title":"Requirement for aspartate-cleaved Bid in apoptosis signalling by DNA-damaging anti-cancer regimens","volume":"279","author":"Werner","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.radonc.2006.07.030_bib36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.radonc.2006.07.030_bib37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng1097-141","article-title":"KILLER\/DR5 is a DNA damage-inducible p53-regulated death receptor gene","volume":"17","author":"Wu","year":"1997","journal-title":"Nat Genet"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814006003082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814006003082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T14:11:26Z","timestamp":1736518286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814006003082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0167814006003082"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2006.07.030","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}